C Rad Earnings Estimate
C Rad Earnings per Share Projection vs Actual
About C Rad Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of C Rad earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current C Rad estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as C Rad fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.C-Rad AB , together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. C-Rad AB was founded in 2004 and is headquartered in Uppsala, Sweden. C RAD operates under Diagnostics Research classification in Sweden and is traded on Stockholm Stock Exchange. It employs 54 people.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in CRAD-B Stock
C Rad financial ratios help investors to determine whether CRAD-B Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CRAD-B with respect to the benefits of owning C Rad security.